Deals
Thermo Fisher to Buy Life Technologies for $13.6 Billion
This article is for subscribers only.
Thermo Fisher Scientific Inc., the second-biggest maker of life-sciences equipment by market value, agreed to buy Life Technologies Corp. for $13.6 billion in cash in a deal that expands its reach in medical testing.
The $76-a-share offer also includes the assumption of $2.2 billion in debt, Waltham, Massachusetts-based Thermo Fisher said in a statement today. With the debt, the deal is valued at about $15.8 billion. The per-share offer is 12 percent more than Life Technologies’ closing price of $68 on April 12.